Journal profile · Medicine-Hematology
Cytokine: X
ISSN 2590-1532 · Elsevier · Netherlands
Cytokine: X: fully open access; APC about USD 2,430; review about 15 weeks (community reports); 0 articles in 2025; indexed in Scopus; the journal's website says it has ceased publication.
The journal's website says it has ceased publication: Title discontinued as of 2024 Source ↗Publisher website ·
Scope
Aims, scope and focus
Cytokine: X is published by Elsevier. By OpenAlex counts of its recent articles, its largest topics are Cytokine Signaling Pathways and Interactions, Research on Leishmaniasis Studies and Leprosy Research and Treatment, together about 23.9% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): Medicine-Hematology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cytokine Signaling Pathways and InteractionsMedicine9%
- Research on Leishmaniasis StudiesMedicine7.5%
- Leprosy Research and TreatmentMedicine7.5%
- Macrophage Migration Inhibitory FactorImmunology and Microbiology6%
- Rheumatoid Arthritis Research and TherapiesMedicine4.5%
- Immune Response and InflammationImmunology and Microbiology4.5%
- Adipokines, Inflammation, and Metabolic DiseasesMedicine4.5%
- Monoclonal and Polyclonal Antibodies ResearchMedicine4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Biochemistry | Q1 | 34/438 | 92nd |
| Hematology | Q1 | 14/137 | 90th |
| Molecular Biology | Q1 | 46/410 | 88th |
| Immunology and Allergy | Q1 | 28/233 | 88th |
| Immunology | Q1 | 32/236 | 86th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 13.2LetPub ·
- SJR 2026-06
- 0.98LetPub ·
- SNIP 2026-06
- 0.81LetPub ·
- h-index
- 17OpenAlex ·
- i10-index
- 22OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 54 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 102 |
| 2025 | 0 | 0 | 129 |
| 2024 | 0 | 0 | 133 |
| 2023 | 0 | 0 | 128 |
| 2022 | 6 | 6 | 183 |
| 2021 | 9 | 9 | 146 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 15 weeksLetPub ·
- Peer review
- Blind peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessLetPub
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,430 / EUR 2,270 / GBP 1,950 / JPY 301,390 | — | — | |
| LetPub | USD 2,000 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- Netherlands
- Language
- English
- ISSN
- 2590-1532
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Cytokine: X
How long does peer review take at Cytokine: X?
Authors report an average review time of about 15 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Cytokine: X?
According to LetPub and DOAJ records, Cytokine: X is indexed in Scopus.
Is Cytokine: X open access, and what is the APC?
Cytokine: X is a fully open-access journal. APC about USD 2,430.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .